Holen Sie sich die Stockscreener-App
15.36
3.02%
-0.48
Schlusskurs vom Vortag:
$15.84
Offen:
$15.78
24-Stunden-Volumen:
133.52K
Relative Volume:
0.79
Marktkapitalisierung:
$1.05B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-13.12%
1M Leistung:
-25.72%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$15.09
$15.78
1-Wochen-Bereich:
$15.09
$18.18
52-Wochen-Spanne:
$14.15
$26.15
Kestra Medical Technologies Ltd Stock (KMTS) Company Profile
Firmenname
Kestra Medical Technologies Ltd
Sektor
Telefon
(425) 279-8002
Adresse
3933 LAKE WASHINGTON BLVD NE, KIRKLAND
Vergleichen Sie KMTS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KMTS
Kestra Medical Technologies Ltd
|
15.34 | 1.05B | 0 | 0 | 0 | 0.00 |
|
ISRG
Intuitive Surgical Inc
|
539.90 | 189.82B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
176.84 | 49.98B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
89.22 | 44.00B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
256.21 | 37.05B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
220.65 | 16.36B | 2.90B | 467.20M | 306.90M | 6.37 |
Kestra Medical Technologies Ltd Stock (KMTS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-31 | Eingeleitet | BofA Securities | Buy |
| 2025-03-31 | Eingeleitet | Goldman | Neutral |
| 2025-03-31 | Eingeleitet | Piper Sandler | Overweight |
| 2025-03-31 | Eingeleitet | Stifel | Buy |
| 2025-03-31 | Eingeleitet | Wells Fargo | Overweight |
| 2025-03-31 | Eingeleitet | Wolfe Research | Outperform |
Alle ansehen
Kestra Medical Technologies Ltd Aktie (KMTS) Neueste Nachrichten
Kestra Medical Technologies (NASDAQ:KMTS) Reaches New 1-Year LowHere's What Happened - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Shares Down 4.9%Should You Sell? - MarketBeat
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Kestra Medical Technologies (NASDAQ:KMTS) Hits New 52-Week LowTime to Sell? - MarketBeat
Kestra Medical: Skipping A Heartbeat (NASDAQ:KMTS) - Seeking Alpha
kestra medical appoints new board member and updates executive contracts By Investing.com - Investing.com Nigeria
kestra medical appoints new board member and updates executive contracts - Investing.com
Kestra Medical Appoints Conor Hanley to Board - TipRanks
Kestra Medical appoints Conor Hanley to board of directors - TipRanks
Kestra Medical Technologies Appoints Conor Hanley as Independent Director Effective June 4, 2025 - marketscreener.com
Kestra Medical Technologies Announces Appointment of Conor Hanley to its Board of Directors - GlobeNewswire
Kestra Medical Technologies (NASDAQ:KMTS) Stock Price Down 5.6%What's Next? - MarketBeat
Analysts Offer Insights on Healthcare Companies: Alphatec Holdings (ATEC), Oric Pharmaceuticals (ORIC) and Kestra Medical Technologies Ltd. (KMTS) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT) and Pfizer (PFE) - The Globe and Mail
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Receives $27.50 Consensus PT from Analysts - MarketBeat
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
Optimistic Buy Rating for Kestra Medical Technologies Ltd. Driven by Strategic Expansion and Promising Financial Outlook - TipRanks
Ernst & Young LLP Names Brian Webster of Kestra Medical - GlobeNewswire
Ernst & Young LLP Names Brian Webster of Kestra Medical Technologies as an Entrepreneur Of The Year® 2025 Mountain West Award Finalist - The Manila Times
Ernst & Young LLP Names Brian Webster of Kestra Medical Technologies as an Entrepreneur Of ... - Eagle-Tribune
Kestra Medical Technologies (NASDAQ:KMTS) Shares Down 7.5%Should You Sell? - MarketBeat
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Kestra Medical Technologies to Participate in Upcoming Investor Conferences - GlobeNewswire
Digital Health Leader Kestra Medical Secures Speaking Slots at Two Major Healthcare Conferences - Stock Titan
Kestra Showcases Real-World Outcomes for ASSURE WCD at Heart Rhythm 2025 - GlobeNewswire
Brokerages Set Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Target Price at $27.50 - Defense World
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Kestra Medical Technologies to Showcase Innovation in Sudden Cardiac Arrest Protection and Recovery at Heart Rhythm 2025 - The Manila Times
Kestra Medical Technologies to Showcase Innovation in - GlobeNewswire
Kestra Medical Technologies, Ltd. to Showcase Innovation in Sudden Cardiac Arrest Protection and Recovery At Heart Rhythm 2025 - marketscreener.com
Kestra Medical Technologies (NASDAQ:KMTS) Reaches New 12-Month HighShould You Buy? - MarketBeat
The Goldman Sachs Group Has Lowered Expectations for Kestra Medical Technologies (NASDAQ:KMTS) Stock Price - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Shares Gap Down Following Weak Earnings - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Trading Down 4.3% After Earnings Miss - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Posts Quarterly Earnings Results, Misses Expectations By $0.61 EPS - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Shares Gap Down After Earnings Miss - The AM Reporter
Kestra Medical price target lowered to $23 from $24 at Goldman Sachs - TipRanks
Piper Sandler maintains $27 target on Kestra Medical stock By Investing.com - Investing.com South Africa
Piper Sandler maintains $27 target on Kestra Medical stock - Investing.com Australia
Kestra Medical Technologies revenue jumps 82% to USD 15.1M in Q3 FY25 - Medical Buyer
Finanzdaten der Kestra Medical Technologies Ltd-Aktie (KMTS)
Es liegen keine Finanzdaten für Kestra Medical Technologies Ltd (KMTS) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.01%
0.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):